Aortica gets $7M for 3D-printed surgical tool; 23andMe resumes testing in U.K.;

@FierceMedDev: ICYMI yesterday: Medtronic gets EU regulatory green light for $43 billion merger with Covidien. Article | Follow @FierceMedDev

@EmilyWFierce: Roche acquires prenatal diagnostics outfit Ariosa. Press release | Follow @EmilyWFierce

Three-month-old medical device startup Aortica raised $7 million in a Series A funding round to use toward its 3-D-printed surgical grafting tool. Story

The controversial DNA spit test developed and sold by 23andMe was given a tentative marketing go-ahead in the U.K. Read

Minimally invasive surgical device company Interrad Medical closed a financing round with $7.5 million. Release

Aethlon Medical, a therapeutic device developer targeting infectious disease and cancer, reported results of the use of its Hemopurifier device to treat hepatitis C patients. It is preparing to launch its first U.S. human clinical studies on HCV patients. Release

Biotech News

@FierceBiotech: From FierceBiotechIT: Texas' $3B cancer agency makes computational biology a priority. Article | Follow @FierceBiotech

@JohnCFierce: I wonder if someone would pay me $3.5B for Uncle John's Quiet Time Elixir. (Nyquil and bourbon). $AVNR. | Follow @JohnCFierce

@DamianFierce: Tim Duncan donated $247K to help sequence the genomes of 1,000 cancer patients and publicize the results. Article | Follow @DamianFierce

J&J scuttles a $945M arthritis deal with Astellas on the eve of Phase III. News

GeNeuro snags a $455M deal, inks MS drug pact with Servier. More

Otsuka buys Avanir and its portfolio of repurposed generics for $3.5B. Story

Ascendis banks $60M to get its orphan drug into Phase III. Article

Pharma News

@FiercePharma: NICE changes its attitude on Roche's Gazyvaro. Item | Follow @FiercePharma

@CarlyHFierce: Reuters: In Fresenius, Danone could lose second suitor for nutrition unit. More | Follow @CarlyHFierce

BMS makes cuts in China, reports say up to 1,000. Article

Otsuka spends $3.5B for Avanir--and patent-cliff protection. Story

NICE changes its attitude on Roche's Gazyvaro. More

Biotech Research News

New structural biology software tackles viruses and bacteria. Story

8-year study highlights role of a key protein in cardiomyopathy. More

Binge drinking 'cure' in rats sparks a debate over animal study. Story

Cell research at Brigham & Women's points to a new drug target for fibrosis. Report

Harvard, MIT teams identify a 'pre-malignant' phase for blood cancers. Article

Pharma Manufacturing News

Lyophilization market forecast to double in size by 2020. Article

FDA slaps Dr. Reddy's with a Form 483. Report

Eisai opens new plants targeting Asia and Europe. More

Italy clears Novartis vaccine manufacturing in deaths following vaccinations. Story

Recipharm expands footprint, buys Flamel facility in France for $13.2M. Article